Related Experiment Video

Updated: Jun 26, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.5K

Molecular insights and promise of oncolytic virus based immunotherapy

Mahalaxmi Iyer1, Nandita Ravichandran2, Panimalar Abirami Karuppusamy2

  • 1Department of Microbiology, Central University of Punjab, Bathinda, India.

Advances in Protein Chemistry and Structural Biology
|May 18, 2024
PubMed

Insights

Oncolytic viruses (OVs) offer a novel cancer therapy by selectively destroying tumor cells and stimulating anti-cancer immunity. This approach represents a promising advancement in improving cancer patient survival rates.

Area of Science:

  • Oncology
  • Virology
  • Immunotherapy

Background:

  • Cancer treatment requires therapies targeting aggressive disease mechanisms to improve patient survival.
  • Oncolytic viruses (OVs) are emerging as a promising anticancer strategy.
  • OVs can be naturally occurring or engineered to target tumor cells specifically.

Purpose of the Study:

  • To explore the therapeutic potential of oncolytic viruses (OVs) in cancer treatment.
  • To discuss the mechanisms by which OVs combat cancer.
  • To review approved OV therapies and ongoing clinical research, particularly with adenoviruses.

Main Methods:

  • Review of regulatory-approved oncolytic virus therapies.
  • Discussion of clinical research involving oncolytic adenoviruses.
  • Analysis of OV mechanisms, including direct tumor cell lysis, immune system activation, and gene expression.

Main Results:

  • Oncolytic viruses (OVs) demonstrate efficacy through direct tumor destruction and immune system modulation.
  • Engineered OVs can selectively replicate within tumor tissues, sparing healthy cells.
  • Approved OV therapies and adenovirus research highlight their potential in cancer treatment.

Conclusions:

  • Oncolytic viruses (OVs) represent a novel immunotherapeutic strategy for cancer treatment.
  • The selective targeting and immune-stimulating properties of OVs offer a less harmful approach to cancer therapy.
  • Further research into OVs, including adenoviruses, holds significant promise for future cancer treatment modalities.
Keywords:
Cancer therapyDouble stranded virusImmunologyOncolytic virusSingle stranded virus

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

9.1K
Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus06:14

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus

Published on: May 13, 2021

6.5K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
515
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
355
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
892
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K